For the quarter ending 2026-03-31, NEWTO had $92,725K increase in cash & cash equivalents over the period. -$257,549K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 |
|---|---|---|
| Net income | 13,401 | 60,512 |
| Net unrealized depreciation (appreciation) on joint ventures and other investments | -2,523 | -4,405 |
| Net gain (loss) on loans accounted for under the fair value option | -49,578 | 61,157 |
| Net gain on residuals in securitizations | 56,144 | 30,015 |
| Net loss on loan servicing assets | -6,197 | -16,692 |
| Net unrealized (appreciation) depreciation on warrants and derivative transactions | 249 | 74 |
| Unrealized loss on assets classified as held for sale | - | 0 |
| Net gain on sales of loans | 26,682 | 47,555 |
| Net accretion of premium/discount on debt securities available-for-sale and loans | -400 | 1,319 |
| Loss on extinguishment of debt, deferred financing costs expensed | - | -158 |
| Amortization of deferred financing costs and deferred loan fees and costs | 1,420 | 4,396 |
| Provision for credit losses | 9,608 | 38,729 |
| Lower of cost or market adjustment on loans held for sale | 24 | 12 |
| Bad debt expense, net of recoveries | -107 | 283 |
| Stock compensation expense | 565 | 4,097 |
| Deferred income tax (benefit) expense | -16,996 | 8,482 |
| Depreciation and amortization | 36 | 668 |
| Proceeds from sale of loans held for sale | 118,869 | 404,547 |
| Sale of loans held for sale from affiliate | - | 0 |
| Purchase of loans held for sale | 22,179 | - |
| Funding of loans held for sale | 267,951 | 1,062,896 |
| Principal received on loans held for sale | 4,707 | 23,128 |
| Principal received on investments | - | 0 |
| Other, net | 186 | 1,249 |
| Settlement receivable | 51,074 | -52,027 |
| Dividends receivable | - | 0 |
| Other assets | 3,856 | 21,104 |
| Assets classified as held for sale | - | 0 |
| Liabilities directly associated with assets classified as held for sale | - | 0 |
| Dividends payable | - | 0 |
| Due to participants | -24,934 | 30,857 |
| Accounts payable, accrued expenses and other liabilities | 5,618 | -2,841 |
| Net cash used in operating activities | -257,460 | -579,241 |
| Principal received on loans held for investment, at fair value | 15,119 | 71,830 |
| Repurchases of loans held for investment, at fair value | 2,987 | 4,669 |
| Net increase in loans held for investment, at cost | -100,083 | -313,270 |
| Proceeds from sales of biller genie and newtek technology solutions, inc | 1,983 | 4,000 |
| Asset purchase of controlling interest in ncl jv, net of cash acquired | - | 10,120 |
| Contributions to joint ventures and other investments | - | 85 |
| Return of capital from joint ventures and other investments | 0 | 14 |
| Purchase of fixed assets | 89 | 106 |
| Sales of federal home loan bank and federal reserve bank stock | -23 | -361 |
| Purchases of federal home loan bank and federal reserve bank stock | 361 | 1,010 |
| Purchases of available-for-sale securities | -8,367 | -19,937 |
| Maturities of available-for-sale securities | 9,500 | 27,700 |
| Acquisitions, net of cash acquired | - | 0 |
| Net cash used in investing activities | -85,262 | -245,292 |
| Borrowing on bank notes payable | 9,852 | 531,200 |
| Repayment on bank notes payable | 193,973 | 353,803 |
| Net increase (decrease) in deposits | 439,462 | 444,352 |
| Repayment of federal home loan bank advances | 561 | 8,026 |
| Proceeds from common shares sold, net of offering costs | - | 5,091 |
| Proceeds from preferred stock, net of offering costs | - | 48,181 |
| Securities purchase and exchange agreement | - | 10,000 |
| Repurchase of common shares under share repurchase plan | - | 1,491 |
| Proceeds from notes-A20258125Notes | - | 0 |
| Proceeds from notes-A2028Notes | - | 0 |
| Proceeds from notes-A20338.375Notes | 15,000 | - |
| Redemption of notes-A2024Notes | - | 0 |
| Redemption of notes-A2026Notes | 87,123 | - |
| Redemption of notes-A2025500Notes | 0 | 30,000 |
| Proceeds from notes-A20298.50Notes | - | 0 |
| Proceeds from notes-A20298.625Notes | - | 0 |
| Proceeds from notes-A20308.375Notes | 0 | 32,000 |
| Purchase of 2029 8.50 notes-A20298.50Notes | - | 67 |
| Payments on notes payable - securitization trusts | 13,287 | 60,404 |
| Proceeds related to residuals in securitizations | 273,074 | 169,420 |
| Dividends paid, net of dividend reinvestment plan | 6,476 | 28,044 |
| Payments of deferred financing costs | 158 | 3,056 |
| Proceeds from common stock issued under espp, net of discount | 70 | 268 |
| Purchase of vested stock for employee payroll tax withholding | 433 | 2,171 |
| Retirement of common shares | - | 0 |
| Net cash provided by financing activities | 435,447 | 753,450 |
| Net increase (decrease) in cash and restricted cash | 92,725 | -71,083 |
| Cash and restricted cashbeginning of period (note 2) | 310,291 | 381,374 |
| Consolidation/(deconsolidation) of cash and restricted cash from controlled investments related to business combinations and dispositions, net of cash paid | - | 0 |
| Cash and restricted cashend of period (note 2) | 403,016 | 310,291 |
NewtekOne, Inc. (NEWTO)
NewtekOne, Inc. (NEWTO)